Watch: vist.ly/5qpg9
In partnership with: @nordrare.bsky.social
#BPDCN #Hematology #RareDisease
Watch: vist.ly/5qpg9
In partnership with: @nordrare.bsky.social
#BPDCN #Hematology #RareDisease
📖 www.genoway.com/fr/science/p...
🐭 www.genoway.com/fr/product/c...
📖 www.genoway.com/fr/science/p...
🐭 www.genoway.com/fr/product/c...
sohoinsider.com/leukemia/pha...
sohoinsider.com/leukemia/pha...
Aptevo Therapeutics Inc APVO stock is surging on Wednesday. As per data from Benzinga Pro, the stock is trading higher with a strong volume of 81.8 million compared to the average volume of 275.3k. What…
Aptevo Therapeutics Inc APVO stock is surging on Wednesday. As per data from Benzinga Pro, the stock is trading higher with a strong volume of 81.8 million compared to the average volume of 275.3k. What…
- Indolent neoplasm of mature B cells—appear w/ cytoplasmic hair-like projections.
- PB cytopenias
- Splenomegaly
- Immunohistophenotyping: CD11c, CD19, CD20 bright, CD22 bright, CD25, CD103, CD123 and CD305 (LAIR)
- BRAF V600E > 95% of cases
#hemesky #pathsky #hemepath
https://cancerletter.com/drugs-and-targets/20260529_8a/
https://cancerletter.com/drugs-and-targets/20260529_8a/
#AML #Haematology #CAR_T
#AML #Haematology #CAR_T
Innate Pharma Regains Its Rights on CD123 Targeting ANKET ® and Announces Sanofi's Intention to Make a Strategic Investment in the Company
Innate Pharma Regains Its Rights on CD123 Targeting ANKET ® and Announces Sanofi's Intention to Make a Strategic Investment in the Company
By: Bioengineer on Monday, June 15, 2026
By: Bioengineer on Monday, June 15, 2026
By: Daniel Nowak
By: Daniel Nowak
👉 Read more in The Hematologist: https://ow.ly/5q7K50Xa6kb
#MedTwitter #Hematology
👉 Read more in The Hematologist: https://ow.ly/5q7K50Xa6kb
#MedTwitter #Hematology
CD123 can go in the shredder.
CD123 can go in the shredder.
四個核心評分標記是 CD11c、CD103、CD123、CD25,3–4 分見於約 98% 的 HCL;再加 annexin A1(最具特異性)與 CD200。
CD27 不在其中,而且典型為陰性或弱 —— 把它列入特徵標記就錯了。
CD5、CD10、CD23 也都是陰性。
#血液專科
https://hema-2026.hsiehting.com/q/110-048
四個核心評分標記是 CD11c、CD103、CD123、CD25,3–4 分見於約 98% 的 HCL;再加 annexin A1(最具特異性)與 CD200。
CD27 不在其中,而且典型為陰性或弱 —— 把它列入特徵標記就錯了。
CD5、CD10、CD23 也都是陰性。
#血液專科
https://hema-2026.hsiehting.com/q/110-048
HCL:CD11c/CD25/CD103/CD123 四陽、annexin A1 陽性、monocytopenia、BRAF V600E。
HCL variant:CD25 與 CD123 陰性、annexin A1 陰性、無 BRAF V600E、單核球正常。
SMZL:NOTCH2、KLF2、del(7q)。
SDRPL:cyclin D3 過度表現。
#血液專科
https://hema-2026.hsiehting.com/q/112-036
HCL:CD11c/CD25/CD103/CD123 四陽、annexin A1 陽性、monocytopenia、BRAF V600E。
HCL variant:CD25 與 CD123 陰性、annexin A1 陰性、無 BRAF V600E、單核球正常。
SMZL:NOTCH2、KLF2、del(7q)。
SDRPL:cyclin D3 過度表現。
#血液專科
https://hema-2026.hsiehting.com/q/112-036